Concepedia

Lynn Ladutko

LL

Statistics

Publications

5

Citations

333

H-Index

5

Active since

2010

Affiliations

VA Connecticut Healthcare System(Current)

Pfizer (United States)

Yale University

Yale New Haven Hospital

The University of Texas Health Science Center at Tyler

Lynn Ladutko is an author at VA Connecticut Healthcare System specializing in bactericidal agents, tuberculosis pharmacotherapy, and pharmacology.

Publications per year

2010–2017

5

Publications

5

Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

Robert S. Wallis, Wesley Jakubiec, Vikas Kumar et al. · Antimicrobial Agents and Chemotherapy · 2010 · 128 citations · Full text

, , +14

Pharmacokinetics and Whole‐Blood Bactericidal Activity against<i>Mycobacterium tuberculosis</i>of Single Doses of PNU‐100480 in Healthy Volunteers

Robert S. Wallis, Wesley Jakubiec, Vikas Kumar et al. · The Journal of Infectious Diseases · 2010 · 102 citations · Full text

, , +12

Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide

Robert S. Wallis, Wesley Jakubiec, Mark J. Mitton‐Fry et al. · PLoS ONE · 2012 · 74 citations · Full text

, , +15

First Report of Mycobacterium canariasense Catheter-Related Bacteremia in the Americas

Alberto Paniz‐Mondolfi, Lynn Ladutko, Barbara A. Brown‐Elliott et al. · Journal of Clinical Microbiology · 2014 · 17 citations · Full text

, , +16

Mycobacterium grossiae sp. nov., a rapidly growing, scotochromogenic species isolated from human clinical respiratory and blood culture specimens

Alberto E. Paniz‐Mondolfi, Alexander L. Greninger, Lynn Ladutko et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2017 · 12 citations

, , +9

1–5 of 5